Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.
Butzkueven H, Hillert J, Soilu-Hänninen M, Ziemssen T, Kuhle J, Wergeland S, Magyari M, Berger JR, Moore N, Aydemir A, Bezemer I, Sabidó M. Butzkueven H, et al. Among authors: magyari m. Curr Med Res Opin. 2023 Oct;39(10):1367-1374. doi: 10.1080/03007995.2023.2256220. Epub 2023 Sep 7. Curr Med Res Opin. 2023. PMID: 37675878 Free article.
Family planning considerations in people with multiple sclerosis.
Krysko KM, Dobson R, Alroughani R, Amato MP, Bove R, Ciplea AI, Fragoso Y, Houtchens M, Jokubaitis VG, Magyari M, Abdelnasser A, Padma V, Thiel S, Tintore M, Vukusic S, Hellwig K. Krysko KM, et al. Among authors: magyari m. Lancet Neurol. 2023 Apr;22(4):350-366. doi: 10.1016/S1474-4422(22)00426-4. Lancet Neurol. 2023. PMID: 36931808 Review.
Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple Sclerosis.
Kontaxis S, Laporta E, Garcia E, Martinis M, Leocani L, Roselli L, Buron MD, Guerrero AI, Zabala A, Cummins N, Vairavan S, Hotopf M, Dobson RJB, Narayan VA, La Porta ML, Costa GD, Magyari M, Sørensen PS, Nos C, Bailon R, Comi G, On Behalf Of The Radar-Cns Consortium. Kontaxis S, et al. Among authors: magyari m. Sensors (Basel). 2023 Jun 29;23(13):6017. doi: 10.3390/s23136017. Sensors (Basel). 2023. PMID: 37447866 Free PMC article.
[Iodine deficiency in cardiovascular diseases].
Molnár I, Magyari M, Stief L. Molnár I, et al. Among authors: magyari m. Orv Hetil. 1998 Aug 30;139(35):2071-3. Orv Hetil. 1998. PMID: 9755626 Hungarian.
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition.
Solomon AJ, Marrie RA, Viswanathan S, Correale J, Magyari M, Robertson NP, Saylor DR, Kaye W, Rechtman L, Bae E, Shinohara R, King R, Laurson-Doube J, Helme A. Solomon AJ, et al. Among authors: magyari m. Neurology. 2023 Aug 8;101(6):e624-e635. doi: 10.1212/WNL.0000000000207481. Epub 2023 Jun 15. Neurology. 2023. PMID: 37321866 Free PMC article.
Scanner agnostic large-scale evaluation of MS lesion delineation tool for clinical MRI.
Hindsholm AM, Andersen FL, Cramer SP, Simonsen HJ, Askløf MG, Magyari M, Madsen PN, Hansen AE, Sellebjerg F, Larsson HBW, Langkilde AR, Frederiksen JL, Højgaard L, Ladefoged CN, Lindberg U. Hindsholm AM, et al. Among authors: magyari m. Front Neurosci. 2023 May 19;17:1177540. doi: 10.3389/fnins.2023.1177540. eCollection 2023. Front Neurosci. 2023. PMID: 37274207 Free PMC article.
Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis.
Kontaxis S, Laporta E, Garcia E, Guerrero AI, Zabalza A, Matteo M, Lucia R, Simblett S, Weyer J, Hotopf M, Narayan VA, Rashid Z, Folarin AA, Dobson RJB, Buron MD, Leocani L, Cummins N, Vairavan S, Costa GD, Magyari M, Sørensen PS, Nos C, Bailón R, Comi G, The Radar-Cns Consortium. Kontaxis S, et al. Among authors: magyari m. Front Physiol. 2023 Apr 6;14:1145818. doi: 10.3389/fphys.2023.1145818. eCollection 2023. Front Physiol. 2023. PMID: 37089424 Free PMC article.
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Otero-Romero S, Lebrun-Frénay C, Reyes S, Amato MP, Campins M, Farez M, Filippi M, Hacohen Y, Hemmer B, Juuti R, Magyari M, Oreja-Guevara C, Siva A, Vukusic S, Tintoré M. Otero-Romero S, et al. Among authors: magyari m. Mult Scler. 2023 Jul;29(8):904-925. doi: 10.1177/13524585231168043. Epub 2023 Jun 9. Mult Scler. 2023. PMID: 37293841 Free PMC article. Review.
205 results